1. Costing and Cost Analysis in Randomized Controlled Trials

   • Daniel Polsky
   • Henry Glick

   Leading Article 17 September 2012 Pages: 179 - 188

   

2. Cost of Illness of Glaucoma

   • Richard G. Fiscella
   • Jeff Lee
   • John Walt

   Review Article 17 September 2012 Pages: 189 - 198

   

3. The Costs of Treating Breast Cancer in the US

   • Jonathan D. Campbell
   • Scott D. Ramsey

   Review Article 17 September 2012 Pages: 199 - 209

   

4. Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment

   • Esther W. de Bekker-Grob
   • Marie-Louise Essink-Bot
   • Ewout W. Steyerberg

   Original Research Article 17 September 2012 Pages: 211 - 219

   

5. The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone

   • Peter Lindgren
   • Martin Buxton
   • Bengt Jönsson

   Original Research Article 17 September 2012 Pages: 221 - 230

   

6. Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium

   • Lieven Annemans
   • Vanessa Rémy
   • Nathalie Largeron

   Original Research Article 17 September 2012 Pages: 231 - 245

   

7. Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

   • Ataru Igarashi
   • Hiroki Takuma
   • Kiichiro Tsutani

   Original Research Article 17 September 2012 Pages: 247 - 261

   

8. Methods of Economic Evaluation for the German Statutory Healthcare System

   • J. Jaime Caro

   Correspondence 17 September 2012 Pages: 263 - 264

9. Methods of Economic Evaluation for the German Statutory Healthcare System

   • Thomas Mittendorf
   • Wolfgang Greiner
   • Johann-Matthias von der Schulenburg

   Correspondence 17 September 2012 Pages: 265 - 265